AlzChem Group AG
ALZCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.19 | 0.51 | 0.95 | 0.22 |
| FCF Yield | 18.26% | 20.49% | -12.73% | 5.87% |
| EV / EBITDA | 5.28 | 3.73 | 5.05 | 4.69 |
| Quality | ||||
| ROIC | 14.50% | 29.35% | 12.53% | 9.26% |
| Gross Margin | 65.09% | 55.29% | 52.14% | 63.54% |
| Cash Conversion Ratio | 1.40 | 1.51 | -0.10 | 1.18 |
| Growth | ||||
| Revenue 3-Year CAGR | 0.73% | 8.58% | 12.65% | 3.94% |
| Free Cash Flow Growth | 101.76% | 256.46% | -330.01% | -27.15% |
| Safety | ||||
| Net Debt / EBITDA | -0.08 | 0.62 | 1.30 | 0.76 |
| Interest Coverage | 13.40 | 18.70 | 20.26 | 22.44 |
| Efficiency | ||||
| Inventory Turnover | 1.93 | 2.25 | 2.12 | 1.79 |
| Cash Conversion Cycle | 174.61 | 169.62 | 161.31 | 165.76 |